02 Jun 2007 Arrowhead subsidiary, Insert, publishes interim Phase I data from human clinical trials for new cancer drug
02 Jun 2007 Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
01 Jun 2007 Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
01 Jun 2007 Wockhardt gets US FDA nod to enter the $680 million Lamisil market
01 Jun 2007 Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma
01 Jun 2007 Skyepharma PLC - Twice daily ZYFLO CR(TM) (zileuton) extended-release tablets approved by the FDA for asthma
01 Jun 2007 Northstar Neuroscience Announces the Completion of Subject Enrollment and Randomization in the EVEREST Pivotal Trial for Upper Extremity Motor Recovery in Stroke Survivors
01 Jun 2007 Mylan Announces Final FDA Approval for Azithromycin Tablets
01 Jun 2007 Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
01 Jun 2007 ProBioGen and Virbac signed a Licensing Agreement to use ProBioGen’s Novel Avian Cell Line AGE1 for Production of Biological Products
01 Jun 2007 Advanced Cell Technology Enters Into Letter of Intent to Acquire Mytogen, Inc. and Proceed with the Human Clinical Trials Utilizing Myoblasts for the Treatment of Heart Failure
01 Jun 2007 MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of A Hydroxyapatite Coated Stent
01 Jun 2007 Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
31 May 2007 IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
31 May 2007 Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer
31 May 2007 BioWa and Takeda announce licensing of BioWa's POTELLIGENT(R) technology for use in antibody research and development
31 May 2007 Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
31 May 2007 Mersana Therapeutics, Inc. Initiates Phase I Trial of Anti-Cancer Agent, XMT-1001, in Solid Tumors
31 May 2007 CeNeRx BioPharma, Inc. Announces Agreement With PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds
30 May 2007 Positive Final Data from HyCAMPTM Phase II Trial in Metastatic Colorectal Cancer
30 May 2007 Genzyme Corporation to Acquire Bioenvision, Inc.
30 May 2007 Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
30 May 2007 Angiotech initiates european trial examining the Vascular Wrapâ„¢ paclitaxel-eluting mesh for dialysis patients with end-stage renal disease
29 May 2007 Ranbaxy expands its presence in the us dermatology market
29 May 2007 Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up